Overview

Imaging Study of Chronic Low Back Pain in Patients Taking Pain Medication

Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
0
Participant gender:
Male
Summary
Duloxetine has recently been shown to be effective in reducing the pain in chronic pain patients. Duloxetine is known to exert a central mechanism, however the precise human brain structures responsible for mediating its pain-relieving properties are not known. We will use functional magnetic resonance imaging (FMRI) to investigate the neural and functional correlates of pain.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Stanford University
Treatments:
Duloxetine Hydrochloride
Criteria
Inclusion Criteria:- Males aged 18-60

- Back Pain

- Must be able to comply with study visit schedule and other study requirements

- Capable of performing the experimental tasks Exclusion Criteria:- Contraindications
for MRI examination (e.g., metallic implants such as pacemakers, surgical aneurysm
clips, or known metal fragments embedded in the body)

- Known hypersensitivity to duloxetine or any of the inactive ingredients

- Uncontrolled narrow-angle glaucoma